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Abstract 
Disruption of the cytoskeleton and axonal transport has been implicated in certain 
neurodegenerative diseases such as Alzheimer's disease. It is not clear whether 
cytoskeletal and transport abnormalities playa causative role in neurodegeneration or 
whether they are simply byproducts of disrupted metabolism and signal transduction 
pathways in neurons undergoing apoptosis. Aluminum has been used to induce apoptosis 
in both in vivo and in vitro models of apoptosis that share many biochemical and 
pathological similarities to Alzheimer's disease. The specific aim of this project was to 
examine the effect that aluminum-induced apoptosis has on intracellular distribution of 
the endoplasmic reticulum. The results indicate that following aluminum treatment the 
endoplasmic reticulum is abnOlmally clustered around the nucleus, consistent with 
disruption of kinesin-dependent transport. 
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Clustering of the Endoplasmic Reticulum in Aluminum Induced Apoptosis 
Intracellular transport is fundamental to cellular activity and functioning. 
Virtually all eukaryotic cells organize their cytoplasm by translocating various 
membrane-bound vesicles and macromolecular complexes to specific subcellular 
locations. The intracellular traffic is not random, but rather is polar transport along a 
microtubule network. Microtubules serve as the tracks on which molecular motor 
proteins, such as kinesin and dynein, CatTY their cargo. TranspOlt along this cytokeletal 
infrastructure is critical, as materials, such as proteins, produced in specific regions must 
be transported to maintain other regions of the cell. 
Proteins tat'geted for vesicular transpOlt are synthesized by cytosolic ribosomes 
and transpOlted into the endoplasmic reticulum (ER). In the ER, proteins are assembled 
and folded into polypeptide chains in preparation for their secretion or distribution to 
various subcellular compartments. From the ER, proteins are packaged into vesicles and 
transpOlted to the Golgi complex. Proteins undergo sorting and processing in the Golgi 
before being transported along microtubules to their targeted destinations. 
Axonal Transport 
Neurons at'e specialized cells for communication by electrical conduction. The 
axon, the main cellular process of the neuron, is designed to conduct electrical signals 
away from the cell body to adjacent neurons. The axon is suppOlted by cytoskeletal 
neurofilaments and a microtubule network that provides the tracks by which proteins and 
vesicles are transported along the axon. 
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The length of the axon provides the neuron with unique dimensions beyond 
comparison to any other cells in the body. Individual axons can reach a length of over 
one meter in humans and other large animals and the extreme length-to-diameter ratios 
can be as high as 17 in some cases.57 The volume of cytoplasm in these long axons 
accounts for approximately 99% of the cell's volume, while the cell body supplies 
virtually all of the cell's proteins, lipids, and other materials.7 Branching and small 
diameters in parts of the axon further add to the challenge of transpOliing the materials 
necessary for cellular function and maintenance in axons. Such challenges place 
remarkable demands on the neuronal cytoskeleton and associated axonal transport to 
develop and maintain the axon. This critical function has led to increasing research 
focusing on the role of axonal transport defects in neurodegenerative diseases such as 
Alzheimer's disease. 8 
With the recognition that the neuronal cell body is th~ site of synthesis supplying 
the necessary materials to the axon, mechanical models for transport of these materials 
were proposed. Based on his observation of axoplasm oozing from the proximal ends of 
freshly cut giant nerve axons, in 1944 J.Z. Young proposed one of the first models of 
mechanical transport.50 He suggested that a constant production of axoplasm from the 
cell bodies creates a pressure forcing the fluid axoplasm down the length of the axon. He 
proposed that the axon wall, by exerting an opposite pressure due to surface tension of its 
lipid myelin sheath, maintains the cylindrical shape of the axon. 
The first major advancement to the modem concept of axonal transport came in 
1948, when Paul Weiss and H.B. Hiscoe perfOlmed their "damming" experiment and 
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described what would later be termed slow axonal transport.50 They ligated a nerve trunk 
with thread and noticed several days later that the region of the axon before the ligation 
was bulging from what they concluded was damming of axoplasm, while the region of 
the axon beyond the ligation was narrowing. When the ligature was removed, they noted 
that the material proceeded down the axon at the rate of 1-2 mm per day. This 
experiment demonstrated the directional flow of axon-maintaining material from the cell 
body. 
The slow axonal transport observed by Weiss can be subdivided into two 
components: slow component A [0.2-1 mm/day] and slow component B [2-8 mrnJday]. 
Slow transpOlt is well developed in axons and provides the means by which cytoskeletal 
materials required for maintaining the axonal cytoskeleton are transpOlted?6 Slow 
transport is also responsible for the locomotion of the axon in periods of growth and 
regeneration.34 
Whether growing or not, slow axonal transport keeps the axonal polymers in 
continuous motion.36 Slow axonal transport is responsible for moving large amounts of 
cytoskeletal matelials; however, it operates on a local level by moving individual 
polymers within the axon.34 The net result of the movement of individual polymers is a 
translocation of the entire axonal cytoskeleton towards the telminus of the axon. 
Later expeliments with radioactively-tagged amino acids provided evidence for a 
second type of axonal transport, one that moves at a much faster rate.39 Fast axonal 
transport, as it was termed, travels at a rate of 200-400 mm per day. Video microscopy 
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has allowed researchers to directly view vesicles in giant squid axons undergoing fast 
axonal transport.4! 
Fast axonal transport accounts for vesicular traffic within the axon.! Enzymes, 
lipids, and membrane glycoproteins are among the materials canied along the axonal 
microtubules via fast axonal transpOlt. Unlike slow axonal transport, fast axonal 
transport has been experimentally shown to operate in the anterograde and retrograde 
directions.57 
Slow axonal transpOlt has been the subject of some controversy in recent years. 
Recent studies have examined neurofilament proteins tagged with green fluorescent 
protein (GFP) in cultured rat sympathetic neurons.6! The axons of these neurons contain 
relatively few neurofilaments and frequently have gaps lacking neurofilament in their 
axonal cytoskeletal network. Time-lapse imaging of these gaps has allowed the 
observation of axonal transport without the normal photobleaching or photoactivation 
approaches. These studies have produced some surprising results. Contrary to the 
standard association of cytoskeletal materials with "slow" transpOlt, neurofilaments have 
been observed to move rapidly in the axon, with rates as high as 3 /-lm per second.62 This 
rapid movement is interrupted by long pauses, however. Comparing these rapid bursts to 
the net movement of neurofilament proteins at 0.3-3 mm per day, it can be estimated that 
neurofilaments spend 83-99% of their axonal transpOlt in these long pauses. 10 The 
mechanistic reasons behind these pauses has not been determined. 
In 1986, Nixon and Logvinenko used radioisotopic pulse labeling in mouse optic 
nerves to propose a model of two kinetically distinct types of neurofilaments.39 They 
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suggested that neurofilament polymers transition between moving and stationary phase as 
they travel along the axon. Lasek and his associates, however, challenged this model of 
two kinetically different neurofilament populations.35 Lasek suggested that there is a 
single population of neurofilaments in axons and they are all in a continuous state of 
movement, albeit at a broad range of rates. Results showing GFP-tagged neurofilaments 
moving in altemating fits bursts and pauses do not provide conclusive evidence for either 
one of these models. The fits and starts could represent a transition between two distinct 
phases or it could represent ilTegular movements of a single population of 
neurofilaments. 
Another point of controversy in slow axonal transport has been the structural 
forms in which the cytoskeletal and cytosolic proteins move. Slow axonal transport 
consists not only of cytoskeletal proteins, but a wide range of additional cytosolic 
proteins. Lasek proposed a model where these cytosolic proteins are transpolied by 
physically associating with moving cytoskeletal polymers.34 The relatively simple 
protein composition that makes up slow component A indicates that microtubules and 
neurofilaments could act as the only structural carriers for proteins in this component. 10 
Proteins in slow component A are either integral paris of the cytoskeletal polymers or 
have been shown to associate with these polymers in vivo. Slow component B consists of 
a much more diverse and complex protein composition. It is likely that the catTier 
structures for slow component B are likewise complex and may consist of several 
macromolecular complexes. 
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It has been generally held that slow axonal transpOli occurs only in the 
anterograde direction. However, observations of GFP-tagged neurofilaments show that 
up to 20-30% of the filaments move towards the cell body in a retrograde fashion. 62 
Supporting this, in vitro studies have shown neurofilaments moving towards the minus 
ends, as well as the plus ends, of microtubules.48 Retrograde movement of neurofilament 
could indicate a distinct population or transient reversals of filaments that have a net 
movement in the anterograde direction. 
Mitochondlia display unique motility within axons of nerve cells. Unlike many 
other types of organelles, mitochondria undergo net movement of both anterograde and 
retrograde transport within the axon.27 Mitochondlia serve essential functions of aerobic 
ATP production and intracellular calcium regulation to maintain the axon. Movement of 
mitochondria is distinguished by three key elements: saltatory movement, with frequent 
starts and stops; true bidirectional movement; and prolonged $tationary phases.27 
Rapid-freezing electron microscopy demonstrated cross bridges between 
microtubules and mitochondria, indicating that microtubules serve as the tracks for 
mitochondrial axonal transport?S Observation of mitochondrial movement in the growth 
cone region of growing axons of sympathetic neurons in culture demonstrated that 
microfilaments can also serve as mitochondlial tracks. 16 Mitochondria can move 
bidirectionally on either set of cytoskeletal tracks, but there are key differences in 
motility on the different tracks. Mitochondria are transported at a much higher rate on 
microtubules, implying that molecular motors with different characteristics are associated 
with mitochondlial transport on the different tracks. 38 
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Molecular Motors 
To achieve directional transport within the cell, vesicles and organelles must 
associate with motor proteins that simultaneously attach to the microtubule network and 
provide energy for the movement. These motor proteins move unidirectionally along 
microtubules by coupling ATP hydrolysis to force generation. This force allows motor 
proteins to cany their cargo to various destinations in the cell. 
Evidence for a differential transport of components, and the discovery of a fast 
transp0l1 in axons, led to a search for molecular models of transport. In 1964, Lubinska 
observed that acetylcholinesterase not only moved anterogradely to accumulate above a 
nerve ligation, but also accumulated below a second ligation made more proximal to the 
cell body.50 While the total amount of acetylcholinesterase remained the same in a 
segment of axon isolated in such a way, it became redistributed as a result of two-way 
transport. The presence of both anterograde and retrograde transp0l1 provided evidence 
that there is a structure within the neuron's axon that is able to selectively guide axonal 
transp0l1. Based on evidence that microtubules are present in the axon and implicated in 
the transport process, a basic model was established in which carriers moved along 
microtubules using the energy provided by ATP. 
The motor proteins associated with the microtubules during intracellular transport 
were not discovered until the mid-1980's.58 Evidence that these proteins required 
association with both the microtubules and adenosine triphosphate (ATP) pointed to 
mechanochemical ATPases as prime candidates. Dynein, like that which operates in the 
movement of cilia and flagella, had been discovered in the 1960's and was considered for 
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some time. 37 However, advances in technology led to the discovery of the motor protein 
kinesin, and two years later, cytoplasmic dynein.58 
Molecular motor proteins function by converting the chemical energy of ATP into 
a force that propels molecular motion. Association of the motor proteins with the 
microtubules and ATP causes a conformational change in the motor head regions of the 
proteins. This conformational change propels the motor proteins and their associated 
vesicular cargo along the microtubules. 
Kinesin is a 380 kilo Dalton (kD) dimer consisting of two 120-kD heavy chains 
and two 64-kD light chains.26 Kinesin has a rod-like structure with two large globular 
heads, made up of the heavy chains, connected by a stalk region to a fan-like tail, 
comptised of the light chains. While the head region is directly associated with the 
microtubules and ATP, the tail region associates with the membrane vesicles. 19 The head 
region of kinesin generates force for movement and is a highly conserved domain.26 On 
the contrary, the tail region has a highly vatiable amino acid sequence. Kinesin is an 
anterograde motor protein that moves its cargo towards the plus-end of the microtubule, 
or the cell periphery. 
Dynein is the second group of motor proteins and transpOlis its cargo along the 
microtubules toward the minus-end. Cytoplasmic dynein is a member of the dynein 
family that is involved in the movement of vesicles within the cell. It is a huge 
multisubunit protein complex (1.2 mega Daltons) and is found in all eukaryotic cells?6 It 
consists of two heavy chains (-530 kD), three intermediate chains (74 kD), and four light 
intermediate chains (-55 kD). Like kinesin, the two heavy chains comptise two large 
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globular heads that associate with the microtubules and ATP. However, dynein cannot 
directly associate with its vesicular cargo. Vesicular attachment is thus mediated by 
another protein complex known as dynactin. 18 
KINESIN Light Chains 
64kD 
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Coiled Stalk Region 
Heavy Chains 
120kD 
CYTOPLASMIC DYNEIN 
Light Intermediate Chains (4x) 
55kD 
O!III Intermediate Chains (3x) 
74kD 
Heavy Chains 
530kD 
Figure 1. Structural representation of kinesin and cytoplasmic dynein 
motor proteins. 
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Transport Betvveen ER and Golgi 
A unique fonn of intracellular transport of vesicles occurs between the 
endoplasmic reticulum and the Golgi complex. Proteins are assembled and folded in the 
ER, packaged into vesicles, and shipped to the Golgi for processing and transpOlt. 
Transport between these two structures involves an intelmediate compartment and is 
somewhat, though not completely, dependent on microtubules. This specific intracellular 
pathway is clitical, as disruption of this transport could result in an accumulation of 
proteins that could elicit cellular stress responses. 
Proteins that are destined for vesicular traffic in secretory and endocytotic 
pathways are synthesized by ribosomes in the cytosol. These proteins are then co-
translationally transported into the lumen or membrane of the ER. After proper folding 
and oliogomer assembly, the proteins are incorporated into vesicles for transport to the 
Golgi complex. The Golgi complex is responsible for perfonning various tasks such as 
glycosylation of many proteins, sorting of proteins into vesicles, and transport of these 
vesicles to vatious destinations throughout the cel1.2 
TranspOlt of proteins from the ER to the Golgi complex involves transport 
vesicles that bud from the ER membrane and fuse with the membrane of the Goigi 
appat·atus. Early studies using pancreatic acinar cells revealed that vesicle budding 
occurs in specialized regions of the ER known as transitional elements.6o This transport 
has been demonstrated in vitro using permeabilized cells with added cytosolic fraction, 
ATP-regenerating system, and GDP-mannose.4 
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Genetic approaches in Saccharomyces cerevisiae have been important in 
identifying many proteins involved in ER to Golgi transpOlt. GO A group of sec genes-
sec12, secl3, sec16, and sec23- seems to be involved in vesicle formation. Another 
group of sec genes- sec17, sec18, and sec22- appear to be involved in the fusion of these 
vesicles to their targets, such as the Golgi membrane. Another group of proteins, small 
GTP binding proteins, play an important role in the ER to Golgi transport. 60 One such 
protein is Sarlp, which interacts with sec12 and sec23 proteins and the endoplasmic 
reticulum membrane. Sarlp, in conjunction with Sec12p, seems to associate with the 
endoplasmic reticulum and promote the formation of transport vesicles by hydrolyzing 
GTP. The ARF (ADP-Iibosylating factor) family of proteins also seems to be involved in 
ER to Golgi transport and appears to function in the maintenance of the Golgi 
apparatus. 12 
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Table 1. Protein families involved in transpOli between the endoplasmic reticulum and 
the Golgi apparatus. 
Table 1 
Proteins Involved in ER to Golgi Transport 
Family of Proteins 
Sec proteins 
-sec12, see13, sec16, see23 proteins 
- see17, sec18, see22 proteins 
Small GTP binding proteins 
-Sarlp 
ARF proteins 
Function 
Involved in vesicle formation 
Involved in fusion of vesicles to targets 
In association with ER and Sec12p, 
hydrolyzes GTP to promote formation of 
transport vesicles 
Involved in maintenance of Golgi structure 
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Studies have shown that ER to Golgi transport in mammalian cells involves an 
intermediate compartment (IC) between the endoplasmic reticulum and the Golgi.6o 
When cells infected with a temperature-sensitive virus were incubated at 15°C, viral 
glycoproteins accumulated in morphologically distinct structures about 300 nm in 
diameter. 45 Evidence supports the idea that the IC is a distinct intermediate in ER to 
Golgi transport, with no direct continuity with either the ER or the Golgi. The IC appears 
to be a dynamic collection of ER transitional elements and vesicular-tubular clusters 
(VTC)3. The IC compartment is involved in the anterograde transport of proteins from 
the ER to the Golgi and the recycling of proteins retrogradely to the ER. 
The retrograde transport of proteins from the Golgi back to the ER has been 
another subject of study in ER to Golgi transport. The anterograde transport pathway is 
mediated by vesicles covered by a protein coatamer, refened to as COPII.46 Association 
of COPII with vesicles targeted for the ER requires GTP and,may involve the GTP-
binding protein ARF. In the retrograde pathway, uncoated, Golgi-derived tubules are 
seen and their presence has been demonstrated to be dependent on microtubules. 13 
Tubular budding, rather than vesicle mediation, has been implicated in retrograde 
transport. 31 This difference in mediation appears evident in experiments that block 
anterograde transport using the drug Brefeldin A. Treatment with Brefeldin A results in 
the disappearance of the Golgi apparatus and subsequent increase in size of the 
endoplasmic reticulum, suggesting that the retrograde pathway dominates.2 
It has recently been clearly demonstrated that transp011 between the intermediate 
compartment and the Golgi apparatus occurs along microtubules. 42,46 Evidence came 
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from cells transfected with VSVG-GFP, a chimaeric protein containing the COOH-
terminal region of a temperature-sensitive vesicular stomatitis virus glycoprotein fused to 
green fluorescent protein. Fluorescence microscopy was used to observe synchronous 
transport of the fusion protein through the secretory pathway. IC membranes containing 
VSVG-GFP were seen to move along microtubules to the Golgi. 42.46 If the microtubules 
are depolymerized, rates of Golgi-dependent protein processing drop dramatically, 
indicating that the transport from the IC to the Golgi has been inhibited. If the 
microtubules are disrupted by a drug such as nocodazole, the microtubule-dependent 
movement from the IC to Golgi is disrupted. However, removal of nocodazole after brief 
exposure can lead to the resumption of normal Ie to Golgi transport. 6 
Interestingly, disruption of microtubules does not always result in decreased rates 
of Golgi-based protein processing or secretion. 32 In these cells that maintain normal 
processing or secretion rates there are considerable changes in the distribution of the 
Golgi, however. In these cells, the Golgi fragments into ministacks which are distributed 
to locations adjacent to endoplasmic reticulum exit sites, at a distance less than 1 !lm. 11 
It seems that diffusion-based membrane trafficking is then used and operates at an 
efficient level. In contrast, in cells with a functional microtubule network, the Golgi can 
be a distance of dozens of micrometers away from the endoplasmic reticulum. 44 
Diffusion would not operate at an efficient enough level at such distances. 
Effects of Aluminum on Transport 
When studying changes in the cytoskeleton and axonal transport in certain 
neurodegenerative diseases, it is useful to establish a biochemical and pathological model 
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of the disease. If one is able to trigger similar changes in a system, whether it is in vivo 
or in vitro, the model may provide clues to the pathological causes of the disease. 
Aluminum can be used to induce a model of apoptosis that shares celiain charactelistics 
with neuronal death in Alzheimer's disease. 
Aluminum is an environmental neurotoxin that has been shown to have an 
inhibitory effect on axonal transport. 29 Aluminum has been shown to cause 
accumulation of neurofilaments in neuronal pelikarya of certain vertebrate species in vivo 
and in vitro. 49 Intrathecal injection of aluminum salts into rabbits induces accumulation 
of neurofilaments, associated with dysfunctional metabolic activity and impaired axonal 
transport of neurofilaments. 17 Chronic exposure of primary cultured neurons to 
aluminum salts also leads to similar neurofilament accumulations in the neuronal 
pelikaryon. 49 In addition, pulse exposure of cultured rat cOliical neurons to aluminum-
maltol causes neurofilaments and fast axonal transpOlied proteins to be abnOlmally 
distributed. 29 
Neurofilaments are clitical to the integlity of a functional cytoskeleton. Thus, 
aluminum-induced abnormalities in neurofilaments would have definite repercussions for 
microtubule-dependent axonal transport processes. The impairment of axonal transport 
by accumulating neurofilaments is thought to be the mechanistic cause of aluminum 
.. 59 tOXICIty. 
Accumulation of neurofilament proteins and abnormal axonal transport are also 
neuronal characteristics of certain neurodegenerative diseases such as Alzheimer's 
disease. 8 The neurofibrillary tangles in AD display a similar, though not identical, 
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accumulation pattern of phosphorylated neurofilament immunoreactivity.56 Thus, there 
may be a similar pathological process causing accumulation of neurofilaments and 
disrupted axonal transport in both neurodegeneration and aluminum neurotoxicity. 
Inducing such effects using aluminum may then provide a useful model for elucidating 
clues about Alzheimer's pathology. 
Alzheimer's and Intracellular Transport 
Alzheimer's disease is characterized by two chief pathological manifestations. 
The first is the presence of extracellular senile plaques composed plimarily of amyloid-~, 
a peptide derived from amyloid precursor protein (~PP). 61 The second of the hallmark 
characteristics is formation of neurofibrillary tangles. The neurofibrillary tangles consist 
of bundles of -10 nanometer paired helical filaments believed to be composed primarily 
of hyperphosphorylated tau. 9 It is not clear whether these pathological characteristics are 
causes or simply markers of Alzheimer's disease. 
The Role of Tau in Neurodegeneration 
As researchers try to determine the biochemical and pathological causes of 
Alzheimer's disease, they have recognized several proteins as key players in the process. 
Tau is a microtubule-associated protein that seems to be critical to the integrity of the 
cytoskeletal network. Tau is associated with the neurofibrillary tangles characteristic of 
Alzheimer's disease. 
Microtubules are stabilized by a group of microtubule-associated proteins (MAPs) 
that includes MAP2, MAP4, and tau.55 These proteins seem to play an important role in 
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cytoskeletal organization by binding to the surface of the microtubules and promoting 
microtubule assembly.3D Tau is especially prevalent in the axons. 
Paired helical filaments in tangles consist of hyperphosphorylated tau. As 
discussed, microtubules compose the cytoskeleton of the cell and are involved in various 
processes within the cell such as transport of vesicles and organelles. Tau normally 
stabilizes microtubules, but when it is abnormally phosphorylated it forms tangles.23 
Accumulation of paired helical filaments is believed to disrupt the cytoskeleton and 
axonal transpOlt, affecting cell metabolism and leading to neuronal death.51 
There seems to be a critical regulated balance of tau phosphorylation, distribution, 
and concentration within the neuron. Kinases and phosphatases seem to regulate this 
balance, which is disturbed in Alzheimer's disease. 8 In AD, tau concentrations are 
elevated and tau becomes localized in the somatodendritic pOltion of the neuron 22 
Elevation of tau concentrations in AD could be attribllted to overcompensation by 
the cell. Upon hyperphosphorylation, tau has reduced affinity for the microtubules 23 
The cell may try to compensate by producing more tau. Research shows that 
overexpression of tau results in change in cell shape, blocking of kinesin movement, and 
altered distribution of organelles and vesicles.51 Following tau overexpression, there is 
perinuclear clustering of the mitochondria at the microtubule-organizing center. Also, 
the ER becomes less dense and moves away from the periphery of the cell. 
Overexpression of tau and subsequent disruption in axonal transport are similarly 
observed in the neurons of Alzheimer's patients.8 
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The role of microtubule transport in abnormal distribution of organelles following 
tau expression has been verified by using drugs that affect the microtubule network. Tau 
overexpression induces clustering of organelles, however, upon treatment with 
nocodazole, a drug that leads to the disassembly of the microtubule network, 
mitochondria redistribute themselves throughout the cell, seemingly by diffusion. 14 
Removing nocodazole reconstitutes the microtubule network and again leads to 
mitochondrial clustering around the microtubule-organizing center. These results 
demonstrate that the process of mitochondrial clustering is indeed dependent on 
microtubule transpOli. 
Distribution of the ER is also dependent on the microtubule network and kinesin 
transport. The distribution behavior of the ER, however, seems to involve more than the 
mitochondria. Treatment with nocodazole does not cause the ER to expand to its normal 
distribution to the cell periphery. The ER is not able to simply diffuse to normal 
distribution throughout the cell in the same way that the mitochondria are able to. These 
results suggest that distributional transport of the ER is dependent on a functional 
microtubule network. 
Changes in the distIibution of organelles such as the mitochondria and ER could 
have important impacts on the cell. IrTegular distribution of the mitochondlia could lead 
to deficient glucose metabolism and ATP synthetase throughout the axon, as 
mitochondria may become concentrated in one region and lacking in another. Abnormal 
distribution of the ER and disruption of its microtubule-dependent secretory pathways 
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could disrupt calcium homeostasis and lipid synthesis. These changes could lead to 
neuronal cell death. 
The Role of~PP in Neurodegeneration 
Another protein that has been the focus of much Alzheimer's research is amyloid 
precursor protein (~PP). While its function in the cell is still in question, it seems to bind 
to kinesin-I and to mediate axonal transport. ~PP is associated with the other hallmark 
characteIistic of Alzheimer's disease, A~ senile plaques. 
Kinesin-I is suggested to be the motor protein responsible for fast anterograde 
axonal transport.58 This motor protein has not been clearly linked to a patiicular type of 
vesicular cargo, nor has a protein receptor assisting in kinesin-I' s binding to its vesicular 
cargo been definitely identified. One of the pIime candidates, however, is ~PP. ~PP has 
been found to mediate the axonal transpOli of presenilin-l and ~-secretase.53 ~PP has 
been linked to the initiation and/or progression of Alzheimer',s disease and has been a 
target of much neurodegenerati ve research. 
~PP is an integral transmembrane protein whose normal role in cellular function 
has not been firmly established. ~PP proteins mature in the ER and Golgi apparatus and 
undergo post-translational modification such as glycosylation and phosphorylation. U-, ~­
, and y-secretases are the three putative proteases that have been implicated in the 
cleavage of mutant ~pp.15 Proteolytic cleavage of ~PP results in the fOlmation of A~ 
peptides of vaIious lengths, though typically consisting of 40 or 42 residues. A~ peptides 
normally exist as soluble monomers, but aggregate into insoluble, fiblillar plaques in the 
brains of AD patients.G3 
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Fragments of ~PP are abundant in the senile plaques characteristic of AD.53 
Some forms of familial Alzheimer's disease are caused by mutants of the ~PP gene. 
Research shows that theses mutants lead to an increase in the number of senile plaques 
and an increase in the proteolytic ~PP fragments in these plaques.47 Abnormal trafficking 
of ~PP has also been suggested as an initiation factor of AD. Evidence of ~PP's direct 
binding to kinesin-I further links it to the disruption of axonal transport characteristic of 
AD. 
While there is controversy over the role of axonal transport defects in the 
initiation of AD, evidence suggests that ~PP's role in transpOlt could be related to 
initiation of AD. ~PP appears to bind directly to kinesin-I and thus is in intimate contact 
with the axonal transport network. Organelle and vesicle accumulations are eady 
changes in morphology in mouse, and perhaps human, models of Alzheimer's disease.2o 
Overexpression of a ~PP homolog, APPL, in Drosophila reslllts in similar axonal clogs 
and disrupts axonal transport.54 Also, while ~PP is widely expressed in the body, cellular 
characteristics of Alzheimer's disease are primarily limited to the neurons. Long axonal 
processes are a distinguishing characteristic of neurons and the critical function of 
transport along these long axons may be important to the development of AD. 
The idea that altered neuronal transpOlt is critical in inducing neuronal death is 
further supported by experiments with axonal blockages. It has been found that reducing 
the amount of kinesin in the axons made blockages worse. On the other hand, reducing 
the amount of dynein or presenilin, a protein responsible for cleavage of ~PP, somewhat 
relieved the axonal blockages. 
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Improperly processed ~pp may accumulate and lead to axonal clogging. 
Increased A~ secretion as a function of stressed neurons may lead to the aggregation of 
amyloid-~ (A~) in senile plaques. This may further disrupt axonal transport and act a 
causative role in neurodegeneration. 
Research shows that ~pp causing neuronal death contains two key regions: the 
amyloid-~ region and the C-terminus. Enzymatic cleavage of the C-telminus liberates 
kinesin because the C-terminus includes the kinesin-binding site. The C-terminus may 
carry a cell-death signal that is released when axonal transport is disrupted. 
Evidence from other models has indicated that defects in transport playa critical 
role in neurodegeneration. Apolipoprotein E (ApoE) is a protein that plays an impOliant 
role in lipid transpOli and is produced in a variety of cells, such as kidney, liver, and fat 
cells. In the brain, ApoE is mainly produced by astrocytes and is important in lipid 
transport within the nervous system. ApoE gene has been lin,ked to increased plaque 
formation in Alzheimer's disease and the early stages of neurofibrillar·y tangles.52 
Neurons undergo uptake and synthesis of ApoE and the regions of the brain where ApoE 
is present are shown to be more susceptible to neurofibrillary tangles. 
Expression of human ApoE4 in the neurons of mice produced axonal transport 
abnormalities, such as accumulation of organelles, and resulted in decreased sensorimotor 
abilities.52 Expression of ApoE4 also results in the hyperphosphorylation of the protein 
tau in the brain and spinal cord, though the mechanism tying these two together is not 
known. This hyperphosphorylation affects the stability of the microtubules and disrupts 
axonal transport. 
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The cytoskeleton and its associated network of intracellular transportation are a 
clitical area of study and research, particularly for their role in neurodegenerative 
diseases such as Alzheimer's disease. It is clear that the integrity of the cytoskeleton and 
transport mechanisms is required for function and survival of neurons. Not surprisingly, 
many neurodegenerative diseases are characterized by abnOlmalities in the cytoskeleton 
and accompanying intracellular transport malfunction. In Alzheimer's disease, 
cytoskeletal abnormalities are so integral that they serve as the basis for the classification 
of the progressive stages of the disease. 8 
Although cytoskeletal and transport abnormalities provide the hallmarks of many 
neurodegenerative diseases, the role they play in the development of the disease is not 
clear. Specifically, it is not clear whether these abnOlmalities playa causative role in 
neurodegeneration or whether they are simply byproducts of disrupted metabolism and 
signal transduction pathways in degenerating neurons. Thus"continued research in the 
role of changes in the cytoskeleton and transport is critical, as they may actively 
contribute to neuronal death and may serve as potential therapeutic targets. 
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Introduction 
Changes in the cytoskeleton and intracellular transpOli were observed in an in 
vitro model of apoptosis. Al-maltolate was used to induce apoptosis in cultured human 
neuroblastoma cells. Specifically, staining techniques were used to observe the effect 
that Al-maltolate treatment has on the intracellular distribution of the endoplasmic 
reticulum. If Al-maltolate affects the intracellular transpOli of the ER, observed changes 
in the density, brightness, and branching of the ER would be expected. The ER is 
normally highly branched and distributed throughout the cell. If the ER is retracted 
toward the nucleus following treatment, however, this would provide evidence that Al-
maltolate affects kinesin dependent transport 
Cell counts were used to establish aluminum's toxicity in the in vitro model. To 
verify that transport effects are specific to Al-maltolate, hydrogen peroxide was also used 
tligger oxidative stress and apoptosis. Examining changes in,such representative models 
may provide clues to the underlying pathological causes of certain types of 
neurodegenerati ve diseases. 
Methods 
Cell Culture 
Human neuroblastoma (NT2) cells (Stratagene) were grown on glass covers lips in 
D-MEMIF-12 (Gibco) growth medium with 10% (v/v) PBS, 2mM L-glutamine and 1 % 
(v/v) penicillin-streptomycin and kept in 5% CO2 at 37°C and 95% humidity. Cells were 
grown at a density of 1 x 105 / mL on the glass coverslips and kept in 6-well plates. 
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Alum.inum Treatment 
Fresh aluminum maltolate was prepared as a stock solution of 25 mM in sterile 
water and filtered through a 0.2 mm filter. Cells were allowed to adhere for 24 hours in 
media containing 0 to 500 ~lM Al-maltolate before the media was replaced. 
Hydrogen Peroxide Treatment 
A solution of 0.03% hydrogen peroxide was prepared in stelile water. Cells were 
incubated in the hydrogen peroxide solution for 30 minutes before the solution was 
replaced with fresh media. 
Visualization of the Endoplasmic Reticulum 
For each six-well plate, three wells containing NT2 cells were incubated in 500 
~M Al-maltolate solution and three wells were incubated in fresh media as controls. To 
visualize the effects on the endoplasmic reticulum, ER-Tracker ™ Blue-White DPX 
(Molecular Probes) was added. This is a fluorescent dye that.specifically detects ER. 
CMXRos Mitotracker Red was added 2~LllOmL for 20 minutes, in order to visualize the 
mitochondria. Following the appropriate incubation, cells were fixed in 4% 
formaldehyde for 15 minutes and then washed with PBS three times. This solution was 
removed with three Ix PBS washes. Coverslips were mounted onto glass slides using 
VectaShield (Vecta Laboratories) and cells were viewed with an Olympus microscope 
and pictures were taken with a digital camera. 
Cell Counts 
Using the Olympus microscope and a digital camera, pictures of ten random, but 
representative, fields were taken for each coverslip. Using Image Pro Plus software, the 
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number of cells per viewing field was calculated by counting the number of nuclei 
stained with Hoechst 33258. Apoptotic cells were identified by strongly condensed or 
fragmented nuclei. Using the total number of cells per coverslip and the conesponding 
number of apoptotic cells, a percentage of apoptotic cells were calculated for each 
coverslip. 
Results 
Cell Count- % Apoptotic Cells 
Hoescht-stained cells were identified as apoptotic based on several criteria, 
including: cell shrinkage, strongly condensed nuclei, and fragmentediilTegular nuclei. 
Percentage of apoptotic cells were calculated for Al-maltolate treated and control cells at 
6- and 24-hour incubation periods. Percentages of apoptotic cells in the AI-treated cells 
for 6- and 24-hour incubation periods were 10.16% and 30.82%, respectively, in the first 
trial. The second trial yielded percentages of apoptotic cells for 6- and 24- hour 
incubations of 33.4% and 45.4%, respectively. Results for the control and AI-treated 
cells in both experimental trials are summarized in Figure 2. 
AI-induced Changes in the Endoplasmic Reticulum 
To visualize the effects of aluminum treatment on the cells, an ER-Tracker ™ 
Blue-White DPX (Molecular Probes) was used. The ER appeared dense and branched in 
control cultures, and was extended throughout the cell to the cell's periphery (Figure 3). 
In AI-treated cells, however, the ER appeared less dense and clustered around the nuclei 
of the cells (Figure 3). 
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Figure 2, Cell number decreased significantly over 24 hours with Al-maltolate treatment 
(top), In addition, a significant increase in the percentage of strongly condensed, 
fragmented, and/or irregular nuclei was observed following incubation with 500 ~lM AI-
maltolate (bottom), 
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Figure 3. ER-Tracker ™ Blue-White DPX reveals clustering of the endoplasmic 
reticulum around the nucleus in NT2 cells incubated in Al-maltolate for 6 hours (left). 
The endoplasmic reticulum ofNT2 cells in control media is highly branched and 
extended to the cell periphery (right). 
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Hydrogen Peroxide-induced Changes in the Endoplasmic Reticulum 
The effects of hydrogen peroxide were also visualized using ER-Tracker ™ Blue-
White DPX. The ER appeared dense and branched in control cultures, and was extended 
throughout the cell to the cell's peliphery (Figure 3). In cells treated with hydrogen 
peroxide, however, the ER appeared decreased and clustered around the nucleus (Figure 
4). Additionally, the cell itself was greatly reduced in size after hydrogen peroxide 
treatment. 
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Figure 4. NT2 cells incubated in hydrogen peroxide have endoplasmic reticulum 
clustered arolmd the nucleus, as revealed by ER-Tracker ™ Blue-White DPX. In 
addition, the cell itself was greatly reduced in size following hydrogen peroxide 
treatment. 
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Discussion 
For this study, an effective model of apoptosis was produced using Al-maltolate. 
The results indicate that a significant percent of cells were apoptotic following aluminum 
treatment based on certain apoptotic clitelia: cell shrinkage, strongly condensed nuclei, 
and fragmentedlinegular nuclei. Apoptosis has been implicated Alzheimer's disease and 
our model shares many biochemical and pathological characteristics with this 
neurodegenerative disease. 
This study specifically examined the effect of aluminum treatment on intracellular 
distribution of the endoplasmic reticulum. The ER is the primary site of protein synthesis 
and assembly in the cel1.2 However, the ER is also involved in controlling intracellular 
Ca2+ levels and regulating cellular responses to stress. Disruption of Ca2+ homeostasis, 
inhibition of protein glycosylation, and accumulation of misfolded proteins in the ER can 
all result in ER stress that ultimately leads to apoptosis.43 
While mitochondria has received much attention for its role in apoptosis and 
neurodegeneration, studies of the involvement of the ER in the pathogenesis of 
neurodegenerative diseases have been relatively few. Research has suggested that ER 
may also play an important role in stress-mediated cell death induced by a wide vatiety of 
insults. Prolonged ER stress and associated misfolded proteins are linked to the 
pathogenesis of certain neurodegenerative diseases such as Alzheimer's.43 However, the 
role of the ER in initiating cell death after prolonged stress is poorly understood. 
The Golgi apparatus is involved with the ER in the vesicular traffic of proteins. 
Transport between these two structures is at least partially dependent on microtubules.46 
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Disruption of this microtubule-mediated transport may lead to the fragmentation of the 
Golgi apparatus. Treatment with the microtubule-disrupting agent, nocodazole, causes 
Golgi proteins to be redistributed to the exit sites of the ER.21 Disruption of ER to Golgi 
transport could cause an accumulation of proteins and lead to stress-mediated cell 
death. 43 
The results of this study show that treatment with Al-maltolate has significant 
effects on intracellular transport of the ER. In treated cells, the ER appeared to be less 
dense and retracted around the nucleus. These results are consistent with the idea that 
transport along the microtubules in the kinesin-dependent, plus-end direction is disrupted. 
The inhibition of kinesin-dependent transport of the endoplasmic reticulum indicated by 
our results is reminiscent of the morphological effects of tau and A~ overexpression.14 
One of the hallmarks of Alzheimer's disease is the presence of cytoskelatal 
abnormalities such as neurofibrillary tangles.9 This study ind,icates that an AI-induced 
model of apoptosis produces pathological changes in the cytoskeletal transport system 
similar to those found in such neurodegenerative diseases. Understanding the underlying 
pathological processes may help us to develop treatments that target the cause of the 
disease, rather than the effects. 
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